PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

NIH scientists unveil characteristic of HIV early in transmission

2011-02-28
(Press-News.org) A new finding from scientists at the National Institutes of Health could help efforts to design vaccines and other prevention tools to block HIV in the early stages of sexual transmission, before infection takes hold. Researchers at the NIH National Institute of Allergy and Infectious Diseases have helped explain genetic differences that can distinguish some early-transmitting HIVs—viruses found in an infected individual within the first month after infection—from forms of HIV isolated later in infection. These genetic features help HIV bind tightly to a molecule called integrin α4β7. According to the scientists, the capacity to bind tightly to α4β7 likely enhances the ability of certain HIV viruses to complete the many steps of sexual transmission and become the "founder" virus that establishes infection in an individual.

The study also sheds light on CD4+ T cells, the primary immune cell targeted by HIV. The authors previously reported that gp120, an HIV surface protein, can bind to integrin α4β7 via a receptor that may be present on the surface of the CD4+ T-cell. α4β7 helps direct HIV-infected CD4+ T cells into the gut, where the virus can then begin to replicate quickly. Given the new finding that certain early-transmitting isolates of HIV can have an affinity for α4β7, the scientists believe it is likely that CD4+ T cells with the α4β7 receptor play an important role in the sexual transmission of HIV.

### For more about NIAID HIV/AIDS research, visit the NIAID HIV/AIDS Web portal (http://www.niaid.nih.gov/topics/hivaids/Pages/Default.aspx).

ARTICLE: F Nawaz et al. The genotype of early-transmitting HIV gp120s promotes α4β7 reactivity, revealing α4β7+/CD4+ T cells as key targets in mucosal transmission. PloS Pathogens. DOI: ppat1001301 (2011).

WHO: NIAID Director Anthony S. Fauci, M.D., is available for interviews.

CONTACT: To schedule interviews, please contact Laura Sivitz Leifman, 301-402-1663, sivitzl@niaid.nih.gov.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov. The National Institutes of Health (NIH)—The Nation's Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.


ELSE PRESS RELEASES FROM THIS DATE:

Advancing delirium care through research

Advancing delirium care through research
2011-02-28
INDIANAPOLIS -- At least seven million hospitalized Americans suffer from delirium each year, however the condition goes unrecognized in more than 60 percent of patients. Even if diagnosed, there is no effective way to treat the condition, which is a growing concern to medical professionals. Researchers, clinicians, and administrators from across the United States will meet in Indianapolis, June 5 - 7 for "Advancing Delirium Care through Research," the inaugural conference of the American Delirium Society, to discuss current and future research and therapy. The scientific ...

Probiotic identified to treat ulcers

2011-02-28
Researchers from Spain have identified a strain of probiotic bacteria that may be useful in treating ulcers caused by Helicobacter pylori. They report their findings in the February 2011 issue of the journal Applied and Environmental Microbiology. "H. pylori is considered one of the major risk factors underlying the development of gastritis and gastric and duodenal ulcers," write the researchers. "Currently, antibiotic-based treatment for H. pylori infection is neither sufficient nor satisfactory, with the most successful treatments reaching 75 to 90% eradication rates. ...

A glass half full

2011-02-28
The key to dealing with some of the challenges life throws at us - including pain, suffering, illness, grief and loss - is to truly appreciate the positive aspects of our life, and not simply focus on the negative. It is important to acknowledge the setbacks, but equal attention and value need to be given to what is going well. This lesson in living, based on the teachings of Buddha, is given by Karen Hilsberg, from the Los Angeles County Department of Mental Health in California in the US, in an article published online in Springer's journal, Mindfulness. Her moving, ...

Mean girls and queen bees: Females threatened by social exclusion will reject others first

2011-02-28
Many studies have suggested that males tend to be more physically and verbally aggressive than females. According to a new study, to be published in Psychological Science, a journal of the Association for Psychological Science, it may not be the case that women are less competitive than men—they may just be using a different strategy to come out ahead. Specifically, women may rely more on indirect forms of aggression, such as social exclusion. To investigate how men and women respond when faced with a social threat, psychological scientist Joyce F. Benenson of Emmanuel ...

Rare gene glitch may hold clues for schizophrenia -- NIH-funded study

Rare gene glitch may hold clues for schizophrenia -- NIH-funded study
2011-02-28
Scientists are eyeing a rare genetic glitch for clues to improved treatments for some people with schizophrenia – even though they found the mutation in only one third of 1 percent of patients. In the study, funded in part by the National Institutes of Health, schizophrenia patients were 14 times more likely than controls to harbor multiple copies of a gene on Chromosome 7. The mutations were in the gene for VIPR2, the receptor for vasoactive intestinal peptide (VIP) – a chemical messenger known to play a role in brain development. An examination of patients' blood ...

GPs take more than a month to record ovarian cancer diagnosis in one in 10 cases

2011-02-28
Family doctors can take more than a month to record ovarian cancer, once diagnosed by a specialist, in one in 10 cases, indicates research published in the launch issue of the new online journal BMJ Open. Ovarian cancer was also incorrectly or prematurely classified in 11% of cases, the data show. The authors base their findings on the "free text" data available in patient records, which are submitted to the General Practice Research Database (GPRD). The GPRD contains long term anonymised medical data on more than four million patients on the lists of a representative ...

Most 'locked-in syndrome' patients say they are happy

2011-02-28
Most "locked-in syndrome" patients say they are happy, and many of the factors reported by those who say they are unhappy can be improved, suggest the results of the largest survey of its kind, published in the launch issue of the new online journal BMJ Open. The findings are likely to challenge the perception that these patients can no longer enjoy quality of life and are candidates for euthanasia or assisted suicide, say the authors. The research team quizzed 168 members of the French Association for Locked in Syndrome on their medical history and emotional state, ...

Baker Institute policy report looks at cybersecurity

2011-02-28
A new article written by a fellow at Rice University's Baker Institute for Public Policy calls on the intelligence community to jointly create a policy on cybersecurity and determine the degree to which the U.S. should protect intellectual property and national infrastructure of other nations. The author also comments on how aggressive the United States should be in its proactive cyber-spying activities. "Treasure Trove or Trouble: Cyber-Enabled Intelligence and International Politics" was authored by Chris Bronk, a fellow of information technology policy at the Baker ...

Serotonin plays role in many autism cases, studies confirm

Serotonin plays role in many autism cases, studies confirm
2011-02-28
SAN ANTONIO (Feb. 24, 2011) — Mouse models are yielding important clues about the nature of autism spectrum disorders, which impact an estimated one in 110 children in the U.S.[1] In labs at the UT Health Science Center San Antonio, researchers are studying strains of mice that inherently mimic the repetitive and socially impaired behaviors present in these disorders. Georgianna Gould, Ph.D., research assistant professor of physiology in the Graduate School of Biomedical Sciences, is eyeing the role that serotonin plays in autism spectrum disorders. Serotonin is known ...

Antioxidants in pecans may contribute to heart health and disease prevention

2011-02-28
Loma Linda, California – A new research study from Loma Linda University (LLU) demonstrates that naturally occurring antioxidants in pecans may help contribute to heart health and disease prevention; the results were published in the January 2011 issue of The Journal of Nutrition. Pecans contain different forms of the antioxidant vitamin E—known as tocopherols, plus numerous phenolic substances, many of them with antioxidant abilities. The nuts are especially rich in one form of vitamin E called gamma-tocopherols. The findings illustrate that after eating pecans, gamma-tocopherol ...

LAST 30 PRESS RELEASES:

Call for papers: 14th Asia-Pacific Conference on Transportation and the Environment (APTE 2025)

A novel disturbance rejection optimal guidance method for enhancing precision landing performance of reusable rockets

New scan method unveils lung function secrets

Searching for hidden medieval stories from the island of the Sagas

Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model

Neuroscience leader reveals oxytocin's crucial role beyond the 'love hormone' label

Twelve questions to ask your doctor for better brain health in the new year

Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes

Study identifies genetic cause for yellow nail syndrome

New drug to prevent migraine may start working right away

Good news for people with MS: COVID-19 infection not tied to worsening symptoms

Department of Energy announces $179 million for Microelectronics Science Research Centers

Human-related activities continue to threaten global climate and productivity

Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued

Unraveling the power and influence of language

Gene editing tool reduces Alzheimer’s plaque precursor in mice

TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies

Twisted Edison: Bright, elliptically polarized incandescent light

Structural cell protein also directly regulates gene transcription

Breaking boundaries: Researchers isolate quantum coherence in classical light systems

Brain map clarifies neuronal connectivity behind motor function

Researchers find compromised indoor air in homes following Marshall Fire

Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality

Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology

'Glass fences' hinder Japanese female faculty in international research, study finds

Vector winds forecast by numerical weather prediction models still in need of optimization

New research identifies key cellular mechanism driving Alzheimer’s disease

Trends in buprenorphine dispensing among adolescents and young adults in the US

Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility

Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity

[Press-News.org] NIH scientists unveil characteristic of HIV early in transmission